Author: Hamano, Emi; Hijikata, Minako; Itoyama, Satoru; Quy, Tran; Phi, Nguyen Chi; Long, Hoang Thuy; Ha, Le Dang; Ban, Vo Van; Matsushita, Ikumi; Yanai, Hideki; Kirikae, Fumiko; Kirikae, Teruo; Kuratsuji, Tadatoshi; Sasazuki, Takehiko; Keicho, Naoto
Title: Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population Cord-id: s7r2pwxn Document date: 2005_4_22
ID: s7r2pwxn
Snippet: We hypothesized that host antiviral genes induced by type I interferons might affect the natural course of severe acute respiratory syndrome (SARS). We analyzed single nucleotide polymorphisms (SNPs) of 2′,5′-oligoadenylate synthetase 1 (OAS-1), myxovirus resistance-A (MxA), and double-stranded RNA-dependent protein kinase in 44 Vietnamese SARS patients with 103 controls. The G-allele of non-synonymous A/G SNP in exon 3 of OAS-1 gene showed association with SARS (p = 0.0090). The G-allele in
Document: We hypothesized that host antiviral genes induced by type I interferons might affect the natural course of severe acute respiratory syndrome (SARS). We analyzed single nucleotide polymorphisms (SNPs) of 2′,5′-oligoadenylate synthetase 1 (OAS-1), myxovirus resistance-A (MxA), and double-stranded RNA-dependent protein kinase in 44 Vietnamese SARS patients with 103 controls. The G-allele of non-synonymous A/G SNP in exon 3 of OAS-1 gene showed association with SARS (p = 0.0090). The G-allele in exon 3 of OAS-1 and the one in exon 6 were in strong linkage disequilibrium and both of them were associated with SARS infection. The GG genotype and G-allele of G/T SNP at position −88 in the MxA gene promoter were found more frequently in hypoxemic group than in non-hypoxemic group of SARS (p = 0.0195). Our findings suggest that polymorphisms of two IFN-inducible genes OAS-1 and MxA might affect susceptibility to the disease and progression of SARS at each level.
Search related documents:
Co phrase search for related documents- aa genotype and acute respiratory syndrome: 1, 2, 3, 4
- acceptor site and activation binding: 1
- acceptor site and luciferase reporter: 1, 2, 3
- activation binding and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- activation binding and luciferase reporter: 1, 2, 3, 4, 5
- activation binding and luciferase reporter assay: 1
- acute respiratory syndrome and luciferase reporter: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- acute respiratory syndrome and luciferase reporter assay: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute respiratory syndrome and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory syndrome and lung sars progression: 1, 2, 3, 4
- long transcript and luciferase reporter: 1
- long transcript and luciferase reporter assay: 1
- luciferase reporter and lung involvement: 1
- luciferase reporter assay and lung involvement: 1
Co phrase search for related documents, hyperlinks ordered by date